4//SEC Filing
Hollander David 4
Accession 0001372514-25-000028
CIK 0001372514other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 8:15 PM ET
Size
5.5 KB
Accession
0001372514-25-000028
Insider Transaction Report
Form 4
Hollander David
Director
Transactions
- Award
Stock Option (right to buy)
2025-04-01+20,000→ 20,000 totalExercise: $2.93From: 2026-04-01Exp: 2035-04-01→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2024 Equity Incentive Plan. The Option will become fully exercisable on April 1, 2026.
Documents
Issuer
KIORA PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001793796
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 8:15 PM ET
- Size
- 5.5 KB